← Back to guidelines
Cardiology1 paper

Idiopathic hepatitis in infancy

Last edited: 4/23/2026

Overview

Idiopathic hepatitis in infancy refers to liver inflammation without a discernible cause, primarily affecting neonates and young infants, often presenting with elevated liver enzymes and potential liver failure 1.

Diagnosis

  • Elevated liver enzymes (ALT, AST) 1
  • Imaging may reveal nonspecific findings; specific diagnostic criteria often rely on exclusion of other causes 1
  • Histopathological examination may show features of hepatocellular injury without clear etiology 1
  • Management

  • Supportive care including hydration, nutritional support, and monitoring for complications 1
  • Liver transplantation may be considered in cases of severe liver failure 1
  • No specific pharmacological treatments are widely recommended based on current evidence 1
  • Special Populations

  • Pregnancy/Twin-Twin Transfusion Syndrome: Pulmonary arterial and intracranial calcifications can occur in affected infants, though not directly related to idiopathic hepatitis 1
  • Key Recommendations

  • Exclude other causes of liver disease through comprehensive clinical evaluation and laboratory testing (Evidence: Expert opinion) 1
  • Initiate supportive care measures tailored to the severity of liver dysfunction (Evidence: Expert opinion) 1
  • Consider liver transplantation for infants with irreversible liver failure (Evidence: Expert opinion) 1
  • References

    1 Kei OC, Duncan WJ, Human DG. Pulmonary arterial and intracranial calcification in the recipient of a twin-twin transfusion. Cardiology in the young 2002. link

    Original source

    1. [1]
      Pulmonary arterial and intracranial calcification in the recipient of a twin-twin transfusion.Kei OC, Duncan WJ, Human DG Cardiology in the young (2002)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG